Literature DB >> 2712596

CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and fallopian tube. I. Immunohistochemical detection.

A Scharl1, G Crombach, M Vierbuchen, H Müsch, A Bolte.   

Abstract

The distribution of cancer antigen 125 (CA 125) has been investigated in normal tissues and carcinomas of the Müllerian duct by immunohistochemical methods using the monoclonal antibody OC 125. Detection of CA 125 was most intense in cryostat sections and decreased in formalin fixed and paraffin embedded tissues according to the duration of fixation. Enzymatic digestion with neuraminidase or alkaline hydrolysis abolished specific staining suggesting the antigen is a sialylsaccharide bound to protein by alkali-labile linkage. Immunohistochemical staining demonstrated the presence of CA 125 in all normal glandular epithelia of the endocervix, endometrium and fallopian tube in different distribution patterns. In normal endometrium the cellular distribution pattern was related to the menstrual cycle. In endocervical, endometrial and tubal adenocarcinomas CA 125 was found in 73% of cases. In glandular structures the antigen was concentrated at the luminal surface of the tumour cells, in solid tumour areas it was spread throughout the cytoplasm or concentrated in large cytoplasmic vacuoles. The expression of CA 125 was considerably lower in solid tumour areas. These data show that CA 125 is not a true "tumour marker", but a product of female genital mucosae and of their cancerous derivates provided their synthesizing ability is not lost in the course of pathologic differentiation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2712596     DOI: 10.1007/BF00931381

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  12 in total

1.  The tumor marker CA 125 is a common constituent of normal cervical mucus.

Authors:  H W de Bruijn; T van Beeck Calkoen-Carpay; S Jager; J M Duk; J G Aalders; G J Fleuren
Journal:  Am J Obstet Gynecol       Date:  1986-05       Impact factor: 8.661

2.  CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and Fallopian tube. II. Immunoradiometric determination in secretions, tissue extracts and serum.

Authors:  G Crombach; A Scharl; H Würz
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

3.  Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125.

Authors:  S E Kabawat; R C Bast; A K Bhan; W R Welch; R C Knapp; R B Colvin
Journal:  Int J Gynecol Pathol       Date:  1983       Impact factor: 2.762

4.  CA 125: a useful marker in endometrial carcinoma.

Authors:  J M Duk; J G Aalders; G J Fleuren; H W de Bruijn
Journal:  Am J Obstet Gynecol       Date:  1986-11       Impact factor: 8.661

5.  CA 125 antigen in human amniotic fluid and fetal membranes.

Authors:  T J O'Brien; J W Hardin; G A Bannon; J S Norris; J G Quirk
Journal:  Am J Obstet Gynecol       Date:  1986-07       Impact factor: 8.661

6.  Ca 125 and Ca 19-9: two cancer-associated sialylsaccharide antigens on a mucus glycoprotein from human milk.

Authors:  F G Hanisch; G Uhlenbruck; C Dienst; M Stottrop; E Hippauf
Journal:  Eur J Biochem       Date:  1985-06-03

7.  A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

Authors:  R C Bast; T L Klug; E St John; E Jenison; J M Niloff; H Lazarus; R S Berkowitz; T Leavitt; C T Griffiths; L Parker; V R Zurawski; R C Knapp
Journal:  N Engl J Med       Date:  1983-10-13       Impact factor: 91.245

8.  Reactivity of a monoclonal antibody with human ovarian carcinoma.

Authors:  R C Bast; M Feeney; H Lazarus; L M Nadler; R B Colvin; R C Knapp
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

9.  The distribution and localization of the monoclonal antibody-defined antigen 19-9 (CA19-9) in chronic pancreatitis and pancreatic carcinoma. An immunohistochemical study.

Authors:  J Makovitzky
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1986

10.  Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix.

Authors:  J M Niloff; T L Klug; E Schaetzl; V R Zurawski; R C Knapp; R C Bast
Journal:  Am J Obstet Gynecol       Date:  1984-04-15       Impact factor: 8.661

View more
  2 in total

1.  CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and Fallopian tube. II. Immunoradiometric determination in secretions, tissue extracts and serum.

Authors:  G Crombach; A Scharl; H Würz
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

2.  Ectopic endometrium in human foetuses is a common event and sustains the theory of müllerianosis in the pathogenesis of endometriosis, a disease that predisposes to cancer.

Authors:  Pietro G Signorile; Feliciano Baldi; Rossana Bussani; Mariarosaria D'Armiento; Maria De Falco; Alfonso Baldi
Journal:  J Exp Clin Cancer Res       Date:  2009-04-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.